Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 3
2007 1
2008 1
2010 2
2011 1
2012 4
2013 3
2014 4
2015 4
2016 3
2017 8
2018 8
2019 12
2020 11
2021 11
2022 5
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR).
Jazieh AR, Bounedjar A, Abdel-Razeq H, Berna Koksoy E, Ansari J, Tfayli AH, Tashkandi EM, Jastaniah WA, Alorabi MO, Darwish AD, Rabea AM, Al Olayan A, Ibnshamsah F, Errihani H, AlKaiyat MO, Hussain F, Alkattan K, Bruinooge SS, Garrett-Mayer E, Tamim H. Jazieh AR, et al. Among authors: tfayli ah. J Immunother Precis Oncol. 2024 May 2;7(2):82-88. doi: 10.36401/JIPO-23-38. eCollection 2024 May. J Immunother Precis Oncol. 2024. PMID: 38721403 Free PMC article.
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort.
Mc Laughlin AM, Helland T, Klima F, Koolen SLW, van Schaik RHN, Mathijssen RHJ, Neven P, Swen JJ, Guchelaar HJ, Dalenc F, White-Koning M, Michelet R, Mikus G, Schroth W, Mürdter T, Brauch H, Schwab M, Søiland H, Mellgren G, Thomas F, Kloft C, Hertz DL; CYP2D6 Endoxifen Percentage Activity Model (CEPAM) Consortium. Mc Laughlin AM, et al. Clin Pharmacol Ther. 2024 Mar 18. doi: 10.1002/cpt.3238. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 38494911
Improved Survival of Young Patients With Breast Cancer 40 Years and Younger at Diagnosis.
El Saghir NS, Khalil LE, El Dick J, Atwani RW, Safi N, Charafeddine M, Al-Masri A, El Saghir BN, Chaccour M, Tfayli A, Assi H, Abbas J, Ayoub Z, Sbaity E, Moukadem HA. El Saghir NS, et al. Among authors: tfayli a. JCO Glob Oncol. 2023 May;9:e2200354. doi: 10.1200/GO.22.00354. JCO Glob Oncol. 2023. PMID: 37229627 Free PMC article. Review.
Frequency and mutational spectrum of PIK3CA gene mutations in breast cancer patients: Largest and first report from Lebanon.
Hamadeh LN, Farhat L, Hilal L, Assi H, Nasr F, Chahine G, Kattan J, Farhat F, Kourie H, El Hachem G, Ghosn M, El Saghir N, Chamseddine N, Finianos A, Ghanem H, Younes A, Gerges DA, Temraz S, Haidar M, Nabhan T, Chamseddine A, Tfayli A, Zaatari G, Mahfouz R. Hamadeh LN, et al. Among authors: tfayli a. Gene. 2023 Jun 30;871:147433. doi: 10.1016/j.gene.2023.147433. Epub 2023 Apr 15. Gene. 2023. PMID: 37068694
Diagnosis and management of patients with stage III non‑small cell lung cancer: A joint statement by the Lebanese Society of Medical Oncology and the Lebanese Pulmonary Society (Review).
Aoun-Bacha Z, Bitar N, Saleh WA, Assi H, Bahous J, Boukhalil P, Chami H, Dabar G, El Karak F, Farhat F, Ghanem H, Ghosn M, Juvelikian G, Nasr F, Nehme R, Riachy M, Tabet G, Tfayli A, Waked M, Youssef P. Aoun-Bacha Z, et al. Among authors: tfayli a. Oncol Lett. 2023 Feb 6;25(3):113. doi: 10.3892/ol.2023.13699. eCollection 2023 Mar. Oncol Lett. 2023. PMID: 36844621 Free PMC article. Review.
Prone versus Supine FDG PET/CT in the Staging of Breast Cancer.
Nassar L, Kassas M, Abi-Ghanem AS, El-Jebai M, Al-Zakleet S, Baassiri AS, Naccoul RA, Barakat A, Tfayli A, Assi H, Berjawi G, Estrada-Lobato E, Giammarile F, Vinjamuri S, Haidar M. Nassar L, et al. Among authors: tfayli a. Diagnostics (Basel). 2023 Jan 19;13(3):367. doi: 10.3390/diagnostics13030367. Diagnostics (Basel). 2023. PMID: 36766472 Free PMC article.
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations.
Khor CC, Winter S, Sutiman N, Mürdter TE, Chen S, Lim JSL, Li Z, Li J, Sim KS, Ganchev B, Eccles D, Eccles B, Tapper W, Zgheib NK, Tfayli A, Ng RCH, Yap YS, Lim E, Wong M, Wong NS, Ang PCS, Dent R, Tremmel R, Klein K, Schaeffeler E, Zhou Y, Lauschke VM, Eichelbaum M, Schwab M, Brauch HB, Chowbay B, Schroth W. Khor CC, et al. Among authors: tfayli a. Clin Pharmacol Ther. 2023 Mar;113(3):712-723. doi: 10.1002/cpt.2846. Epub 2023 Jan 31. Clin Pharmacol Ther. 2023. PMID: 36629403
87 results